ClinicalTrials.gov
public full text
Public Domain
Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma
The purpose of the study is to observe the effect of sorafenib combined with aspirin in preventing the recurrence in high-risk patients with hepatocellular carcinoma.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Effect Of Aspirin On Survival in in Patients Undergoing Chronic Hemodialysis#874435
- Adjuvant Aspirin Treatment for Colon Cancer Patients#1103088
- Open-Label Extension of LOCKCYST Trial#1059118
- PI-88 in Hepatocellular Carcinoma After Hepatectomy#828352
- Efficacy of Adjuvant Mitotane Treatment (ADIUVO)#980170
Record · ID 842529
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive